Ro Health vs Calibrate for Weight Loss: Full 2026 Comparison
An independent, side-by-side comparison of Ro and Calibrate for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Ro
Starting at $149/mo vs $299/mo
Most Medications
Calibrate
3 medications vs 2
Best for Beginners
Ro
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Ro | Calibrate | Savings |
|---|---|---|---|
| Semaglutide | $149/monthly | $299/monthly | Save $150/mo with Ro |
| Tirzepatide | $399/monthly | $299/monthly | Save $100/mo with Calibrate |
| Liraglutide | Not offered | $299/monthly | Only at Calibrate |
Pros and Cons
Ro
- Competitive compounded semaglutide pricing (from $149/mo)
- Large established platform with millions of patients
- Free ongoing provider messaging
- Body program includes metabolic health coaching
- No video consultations — async only
- No lab testing included
- Only offers GLP-1 weight loss medications
- Compounded medications not FDA-approved as finished products
Calibrate
- Comprehensive metabolic health program (not just medication)
- Lab testing and metabolic panels included
- Video consultations with obesity medicine specialists
- Works with insurance to cover GLP-1 medication costs
- Focus on sustainable weight loss and metabolic reset
- Higher program cost ($299/mo for coaching + medication separate)
- One-year commitment required
- Insurance coverage for medication not guaranteed
- Not available in all states
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By Telehealth Ally Editorial Team · Last updated March 29, 2026
Telehealth Ally is editorially independent. We do not accept payment for provider rankings or recommendations.
Ro and Calibrate represent two meaningfully different approaches to GLP-1 telehealth. Whether you're searching "cheapest GLP-1 online" (Ro usually wins) or "ro health vs calibrate which is better for insurance coverage" (Calibrate usually wins), the answer depends heavily on your situation. Ro is built for speed and the lowest possible cash-pay cost — async intake, fast prescriptions, no required appointments. Calibrate is built for clinical depth and long-term outcomes — video consults with obesity medicine specialists, labs included, 1:1 coaching, and active insurance navigation.
Neither is objectively better. The right choice depends on your insurance situation, whether you have comorbidities, and how much clinical oversight you actually want.
Two things have shifted the comparison recently. Calibrate cut its program fee from $299/mo to $199/mo in early 2026, narrowing the cost gap more than most people realize. And Ro is in the process of transitioning away from compounded semaglutide as FDA enforcement tightens — expect more brand-name-only options from Ro by mid-2026.
How do Ro and Calibrate compare on price?
| Ro | Calibrate | |
|---|---|---|
| Program / subscription fee | $0 | $199/mo |
| Compounded semaglutide (injectable) | $149/mo (all-in) | Winding down under FDA enforcement |
| Brand Wegovy (injectable, cash) | $349/mo | Insurance-first (PA support) |
| Oral Wegovy (semaglutide, cash) | $149/mo promo through ~April 15, then $199 | Not offered |
| Zepbound (tirzepatide, cash) | Via insurance only | Insurance-first (PA support) |
| Orforglipron (projected, post-approval) | ~$149/mo + $0 program fee | ~$149/mo + $199/mo program fee |
| Lab work | Not included | Included |
| Consultation type | Async (video available on request) | Video (required) |
| Minimum commitment | None | 3 months |
The bottom line on price: For cash-pay patients, Ro is substantially cheaper — often by $150–$200/mo. For patients with commercial insurance who may qualify for covered brand-name GLP-1s, the gap narrows significantly. Calibrate's $199/mo program fee covers labs, coaching, and active prior authorization support — all of which have real dollar value if insurance is in play.
How do Ro and Calibrate differ in their clinical approach?
Ro
Ro's intake is async by default. You complete a health questionnaire, a provider reviews it, and you receive a prescription — often same-day. No appointment required. The model is optimized for minimal friction.
Providers at Ro are generalist practitioners, not obesity medicine specialists. There's no lab work included, no coaching, and no behavioral support. Unlimited messaging is available for dose adjustments and side effect questions. Ro added insurance navigation for brand medications in 2025, but it's less hands-on than what Calibrate offers.
Best for: Patients who have done their research, know what medication they want, and want the fastest and cheapest path to a prescription. Healthy patients with no significant comorbidities who don't need intensive clinical oversight.
See our full Ro GLP-1 review for a detailed breakdown.
Calibrate
Calibrate requires a video consultation with a board-certified obesity medicine specialist before prescribing. The provider reviewing your case has specific training in metabolic health and weight management, which shapes how they handle comorbidities, titration, and plateaus.
The program includes comprehensive lab panels (fasting glucose, HbA1c, lipid panel, thyroid), 1:1 coaching structured around food, sleep, exercise, and emotional health, and active insurance navigation including prior authorization handling and appeals. Labs continue throughout the program. Calibrate also offers Wegovy HD (semaglutide 7.2mg) for patients who plateau on standard doses — a formulation most telehealth platforms don't carry.
Calibrate's model requires engagement. You're not just receiving medication; you're enrolled in a clinical weight management program.
Best for: Patients with insurance that may cover brand GLP-1s. Patients with comorbidities — pre-diabetes, insulin resistance, hypertension, elevated lipids — who benefit from ongoing monitoring. Patients who want metabolic data alongside weight management, not just a number on the scale.
See our full Calibrate weight loss review for more detail.
What GLP-1 medications does each platform offer?
| Medication | Ro | Calibrate |
|---|---|---|
| Compounded semaglutide (injectable) | ✅ $149/mo | Winding down under FDA enforcement |
| Brand Wegovy (injectable) | ✅ Via insurance | ✅ Primary offering |
| Wegovy HD (semaglutide 7.2mg) | Not offered | ✅ For plateau patients |
| Oral Wegovy (semaglutide) | ✅ $149/mo cash (promo) | ❌ Not offered |
| Zepbound (tirzepatide) | ✅ Via insurance only | ✅ Insurance-first |
| Compounded tirzepatide | ❌ | ❌ |
| Orforglipron | Expected post-approval | Expected post-approval |
Calibrate's medication philosophy is insurance-first. They prescribe brand-name medications and actively work to get them covered. For cash-pay patients, the math changes once orforglipron receives FDA approval — projected at $149/mo. Combined with Calibrate's $199/mo program fee, that would be approximately $348/mo for clinical-grade telehealth with labs and coaching. That's $199/mo more than Ro for compounded semaglutide, but substantially closer than before the price cut.
See the orforglipron complete guide for current approval timeline and expected pricing.
Clinical Support Features
| Feature | Ro | Calibrate |
|---|---|---|
| Consultation type | Async (default) | Video (required) |
| Provider specialty | Generalist | Obesity medicine specialist |
| Lab work | ❌ Not included | ✅ Included |
| 1:1 coaching | ❌ | ✅ |
| Insurance navigation | Basic | Comprehensive (PA + appeals) |
| Minimum commitment | None | 3 months |
| State availability | 50 states | Limited (not all states) |
| HSA/FSA eligible | ✅ | ✅ |
What weight loss outcomes do Ro and Calibrate patients achieve?
Ro does not publish clinical outcomes from its own patient population. Results depend on the GLP-1 prescribed and patient adherence. Clinical trials for semaglutide show roughly 15% body weight reduction at maintenance doses. Real-world results vary.
Calibrate reports 19% average weight loss at 36 months across its patient population. The program includes a 10% body weight money-back guarantee for patients who complete 12 months without reaching that threshold.
These numbers are not directly comparable. Calibrate's outcomes reflect a full clinical program — labs, coaching, active monitoring, and structured behavioral support. Ro's outcomes reflect whatever the medication does for a given patient. Treating these as equivalent data points would be misleading.
Who should use Ro for GLP-1 weight loss?
- You're paying cash and want the lowest monthly cost
- You don't have significant comorbidities and don't need clinical monitoring
- You're needle-averse and want to try oral Wegovy
- You've already been on a GLP-1 and know your dose and tolerability
- You're comfortable with async care and can advocate for yourself when issues come up
Who should use Calibrate for GLP-1 weight loss?
- You have commercial insurance and may qualify for covered brand-name GLP-1s — Calibrate's prior auth team can make a real difference here
- You're on Medicare and want access to CMS-negotiated pricing, now live
- You have comorbidities where lab monitoring matters (pre-diabetes, insulin resistance, high blood pressure, dyslipidemia)
- You want to understand your metabolic health beyond body weight — Calibrate's labs and four-pillar coaching address this directly
- You're concerned about muscle loss during rapid weight loss — Calibrate's resistance training emphasis is built into the protocol
- You're willing to commit to three months in exchange for structured clinical support
Bottom Line
If you're cash-pay and healthy, Ro delivers medication at the lowest price with the least friction. If you have insurance or comorbidities, Calibrate's clinical depth and insurance support usually justify the program fee.
Calibrate's 2026 price cut to $199/mo changes the calculus more than most people are acknowledging. The previous framing — Calibrate at $299/mo is for patients who can afford premium care — no longer applies cleanly. At $199/mo, Calibrate is within realistic range for patients who might otherwise pay $149/mo at Ro for compounded semaglutide, especially if there's any realistic path to insurance coverage. Getting one month of brand Wegovy covered through insurance could offset multiple months of Calibrate's program fee.
What you need from a weight loss program determines which platform fits: medication delivery at the lowest cost, or clinical care with insurance navigation and monitoring.
Frequently Asked Questions
Is Ro or Calibrate cheaper?
It depends on your insurance. Cash-pay with no insurance: Ro is cheaper, often significantly. With commercial insurance that may cover a brand-name GLP-1: Calibrate's $199/mo program fee can pay for itself quickly if their team successfully gets your medication covered. One approved prior authorization can represent thousands of dollars in medication savings annually.
Does Ro do labs?
No. Ro does not include lab work. Calibrate includes a comprehensive lab panel at intake and continues monitoring throughout the program. If you want metabolic data — fasting glucose, HbA1c, thyroid, lipids — you'll need to order labs independently through Ro, or choose Calibrate.
Can I switch from Ro to Calibrate?
Yes. There's no technical barrier to switching. Your medical records can be transferred, and Calibrate will conduct its own intake evaluation. Patients sometimes start at Ro to begin medication quickly and transition to Calibrate when they want more clinical structure, or when insurance coverage becomes viable.
Related comparisons: Found vs Calibrate · Hims vs Ro for weight loss · Best GLP-1 programs 2026
Related Guides
Aleniglipron: Structure Therapeutics' Oral GLP-1 — What Patients Need to Know
Complete guide to aleniglipron, Structure Therapeutics' investigational oral GLP-1 showing 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II — the highest weight loss reported for any oral GLP-1 to date. Only 3.7% discontinuation rate. Phase 3 expected H2 2026, with earliest FDA approval in 2028 or later.
Read guide →Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best GLP-1 Weight Loss Programs 2026: Every Major Provider Ranked
Every major GLP-1 weight loss program ranked — real pricing, clinical models, and honest assessments. No provider paid for placement.
Read guide →